These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11808176)

  • 41. Toward rubella elimination in Poland: need for supplemental immunization activities, enhanced surveillance, and further integration with measles elimination efforts.
    Zimmerman L; Rogalska J; Wannemuehler KA; Haponiuk M; Kosek A; Pauch E; Plonska E; Veltze D; Czarkowski MP; Buddh N; Reef S; Stefanoff P
    J Infect Dis; 2011 Jul; 204 Suppl 1():S389-95. PubMed ID: 21666189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Seroepidemiology of rubella in northern Greece.
    Gioula G; Diza-Mataftsi E; Alexiou-Daniel S; Kyriazopoulou-Dalaina V
    Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):631-3. PubMed ID: 15243817
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors associated with low immunity to rubella infection on antenatal screening.
    Sathanandan D; Gupta L; Liu B; Rutherford A; Lane J
    Aust N Z J Obstet Gynaecol; 2005 Oct; 45(5):435-8. PubMed ID: 16171483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rubella and congenital rubella syndrome--United States, 1985-1988.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1989 Mar; 38(11):173-8. PubMed ID: 2493569
    [No Abstract]   [Full Text] [Related]  

  • 45. Prospective evaluation of pregnant women vaccinated against rubella in southern Brazil.
    Minussi L; Mohrdieck R; Bercini M; Ranieri T; Sanseverino MT; Momino W; Callegari-Jacques SM; Schuler-Faccini L
    Reprod Toxicol; 2008 Jan; 25(1):120-3. PubMed ID: 17977696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. WHO European Region's strategy for elimination of measles and congenital rubella infection.
    Hanon FX; Spika John J; Wassilak Steven S; Emiroglu N
    Euro Surveill; 2003 Jun; 8(6):129-30. PubMed ID: 12878802
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Seroepidemiological survey of rubella immunity among three populations in Shiraz, Islamic Republic of Iran.
    Doroudchi M; Dehaghani AS; Emad K; Ghaderi AA
    East Mediterr Health J; 2001; 7(1-2):128-38. PubMed ID: 12596962
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Rubella and prospects for vaccine prophylaxis of it].
    Malinina OIu
    Tr Inst Im Pastera; 1992; 67():116-21. PubMed ID: 8539763
    [No Abstract]   [Full Text] [Related]  

  • 49. Rubella and congenital rubella syndrome--United States, 1994-1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Apr; 46(16):350-4. PubMed ID: 9148137
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survey of postpartum rubella vaccination, Montreal, Laval, and Montérégie, Quebec, 1992.
    Can Commun Dis Rep; 1996 Mar; 22(5):38-40. PubMed ID: 8680372
    [No Abstract]   [Full Text] [Related]  

  • 51. Rubella serosurveys at three Aravind Eye Hospitals in Tamil Nadu, India.
    Vijayalakshmi P; Anuradha R; Prakash K; Narendran K; Ravindran M; Prajna L; Brown D; Robertson SE
    Bull World Health Organ; 2004 Apr; 82(4):259-64. PubMed ID: 15259254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcome of pregnancy after maternal reinfection with rubella.
    Morgan-Capner P; Miller E; Vurdien JE; Ramsay ME
    CDR (Lond Engl Rev); 1991 May; 1(6):R57-9. PubMed ID: 1669775
    [No Abstract]   [Full Text] [Related]  

  • 53. Age specific rubella seroprevalence of an unvaccinated population of adolescents in Ankara, Turkey.
    Kanbur NO; Derman O; Kutluk T; Kinik E
    Jpn J Infect Dis; 2003 Feb; 56(1):23-5. PubMed ID: 12711822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan.
    Tseng HF; Chang CK; Tan HF; Yang SE; Chang HW
    Vaccine; 2006 Jul; 24(29-30):5772-7. PubMed ID: 16759764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of antibodies against rubella virus in Spain.
    Eiros Bouza JM; Luquero Alcalde FJ; Castrodeza Sanz JJ; Bachiller Luque MR; de Lejarazu Leonardo RO
    Clin Infect Dis; 2007 Feb; 44(3):465-6. PubMed ID: 17205464
    [No Abstract]   [Full Text] [Related]  

  • 56. [Seroprevalence of rubella among the young female healthcare personnel in the Mahdia Sfar teaching hospital, Tunisia].
    Ben Haj Khalifa A; Berriri S; Kheder M
    Med Mal Infect; 2011 Sep; 41(9):493-4. PubMed ID: 21764535
    [No Abstract]   [Full Text] [Related]  

  • 57. Surveillance of congenital rubella syndrome in Japan, 1978-2002: effect of revision of the immunization law.
    Katow S
    Vaccine; 2004 Sep; 22(29-30):4084-91. PubMed ID: 15364460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance.
    Pistol A; Hennessey K; Pitigoi D; Ion-Nedelcu N; Lupulescu E; Walls L; Bellini W; Strebel P
    J Infect Dis; 2003 May; 187 Suppl 1():S217-22. PubMed ID: 12721916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The evidence for the elimination of rubella and congenital rubella syndrome in the United States: a public health achievement.
    Reef SE; Cochi SL
    Clin Infect Dis; 2006 Nov; 43 Suppl 3():S123-5. PubMed ID: 16998770
    [No Abstract]   [Full Text] [Related]  

  • 60. Anniversary of rubella epidemic.
    Armstrong N; O'Donnell N
    Lancet; 2004 Jul 24-30; 364(9431):328. PubMed ID: 15276386
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.